These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8559633)

  • 1. Bacteriology and beta-lactamase activity in ear aspirates of acute otitis media that failed amoxicillin therapy.
    Brook I; Yocum P
    Pediatr Infect Dis J; 1995 Sep; 14(9):805-8. PubMed ID: 8559633
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
    Harrison CJ; Woods C; Stout G; Martin B; Selvarangan R
    J Antimicrob Chemother; 2009 Mar; 63(3):511-9. PubMed ID: 19174454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinicobacteriologic study on clavulanic acid/amoxicillin in pediatric acute otitis media].
    Sugita R; Harada S; Deguchi K; Fujimaki Y; Naito M; Komatsu N; Nomura T; Okano K; Tanaka M; Shimizu K; Watanabe H; Kimura S; Yoshida Y; Senba T; Uchida T
    Jpn J Antibiot; 1999 Oct; 52(10):595-612. PubMed ID: 10638456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiology of acute otitis media recently treated with aminopenicillins.
    Block SL; Hedrick JA; Tyler RD; Smith RA; Harrison CJ
    Pediatr Infect Dis J; 2001 Nov; 20(11):1017-21. PubMed ID: 11734704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in nasopharyngeal bacterial flora in children with nonsevere recurrent acute otitis media and chronic otitis media with effusion: implications for management.
    Marchisio P; Claut L; Rognoni A; Esposito S; Passali D; Bellussi L; Drago L; Pozzi G; Mannelli S; Schito G; Principi N
    Pediatr Infect Dis J; 2003 Mar; 22(3):262-8. PubMed ID: 12634589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Lactamase-producing Moraxella catarrhalis may prevent the emergence of penicillin-resistant Streptococcus pneumoniae in children with recurrent acute otitis media.
    Joki-Erkkilä VP; Aittoniemi J; Vuento R; Puhakka H
    Int J Pediatr Otorhinolaryngol; 2002 May; 63(3):219-22. PubMed ID: 11997157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Past, present, and future: an overview of the microbiology of acute otitis media.
    Harrison CJ
    Postgrad Med; 2005 Dec; 118(6 Suppl Emerging):32-3, 13-23. PubMed ID: 19667701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is beta-lactamase-producing bacteria of major importance for unfavourable development of acute otitis media?
    Prellner K
    Acta Otolaryngol Suppl; 1992; 493():109-11. PubMed ID: 1636409
    [No Abstract]   [Full Text] [Related]  

  • 9. Resistant bacteria in middle ear fluid at the time of tympanotomy tube surgery.
    Sutton DV; Derkay CS; Darrow DH; Strasnick B
    Ann Otol Rhinol Laryngol; 2000 Jan; 109(1):24-9. PubMed ID: 10651407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otitis media with effusion in Lebanese children: prevalence and pathogen susceptibility.
    Nasser SC; Moukarzel N; Nehme A; Haidar H; Kabbara B; Haddad A
    J Laryngol Otol; 2011 Sep; 125(9):928-33. PubMed ID: 21838958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating acute otitis media post-PCV-7: judicious antibiotic therapy.
    Casey JR
    Postgrad Med; 2005 Dec; 118(6 Suppl Emerging):32-3, 24-31. PubMed ID: 19667702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media.
    Jacobs MR; Dagan R; Appelbaum PC; Burch DJ
    Antimicrob Agents Chemother; 1998 Mar; 42(3):589-95. PubMed ID: 9517937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children.
    Piglansky L; Leibovitz E; Raiz S; Greenberg D; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2003 May; 22(5):405-13. PubMed ID: 12792379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of amoxycillin/clavulanic acid (augmentin) against beta-lactamase-positive S. aureus, H. influenzae and B. catarrhalis in an in vitro kinetic model.
    Cooper CE; Slocombe B; White AR
    J Chemother; 1989 Jul; 1(4 Suppl):350-1. PubMed ID: 16312434
    [No Abstract]   [Full Text] [Related]  

  • 15. Increasing antibiotic resistance: its effect on the therapy for otitis media.
    Sagraves R
    J Pediatr Health Care; 2002; 16(2):79-85. PubMed ID: 11904642
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
    Pottumarthy S; Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Antimicrob Chemother; 2007 Aug; 60(2):323-7. PubMed ID: 17562681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
    Yourassowsky E; Van der Linden MP; Crokaert F
    Chemotherapy; 1992; 38(1):7-13. PubMed ID: 1618006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of resistant organisms in otitis media.
    Dagan R
    Pediatr Infect Dis J; 2000 Apr; 19(4):378-82. PubMed ID: 10783039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel.
    Stone KC; Dagan R; Arguedas A; Leibovitz E; Wang E; Echols RM; Janjic N; Critchley IA
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2230-5. PubMed ID: 17387157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.